Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

FDA in Novartis cancer drug U-turn

February 24, 2015
Research and Development, Sales and Marketing Cancer, FDA, Farydak, Novartis, Revlimid, Velcade, myeloma

The FDA has overturned an earlier advisory committee recommendation and decided to approve Novartis’ blood cancer drug Farydak. In November …

News
GSK image

Official linked to GSK bribes facing prison

February 20, 2015
Sales and Marketing China, Deirdre Connelly, GSK, Jack Bailey, Novartis, bribes

A Chinese health official linked to the GSK bribery scandal has been sentenced to 19 years in prison. Huang Fenping, …

News

UK pharma commits at least ‘one code breach a week’

February 18, 2015
Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code

Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …

News
fda

FDA approves Eisai thyroid drug, fast-tracks Novartis heart pill

February 16, 2015
Sales and Marketing Eisai, FDA, LCZ696, Lenvima, Novartis, heart, lenvatinib, thyroid

The FDA has approved Eisai’s thyroid cancer drug Lenvima and also granted Novartis heart pill LCZ696 a priority review.  Lenvima …

News
GSK vaccine image

GSK buys bacteria vaccine firm

February 11, 2015
Research and Development, Sales and Marketing EC, GSK, GlaxoSmithKline, GlycoVaxyn, Novartis, vaccines

GlaxoSmithKline is continuing the significant expansion of its vaccine business with the purchase of Swiss biopharma company GlycoVaxyn. The UK …

News
GSK image

GSK-Novartis mega-deal signed-off by EC

January 29, 2015
Research and Development, Sales and Marketing Abbott, GSK, Mylan, Novartis, acquisition, etc, merger

The European Commission has approved a GSK-Novartis M&A deal, in which GSK will purchase Novartis’ vaccines unit and Novartis will …

News
AZ image

AstraZeneca dives into gene editing

January 29, 2015
Research and Development, Sales and Marketing AstraZeneca, Intellia Therapetics, Novartis, Thermo Fisher Scientific, Wellcome Trust Sanger Institute in Cambridge, Whitehead, broad institute, crispr, the Innovative Genomics Initiative in California

AstraZeneca is looking to harness the power of a pioneering genome-editing tool in a series of new collaborations. The UK …

News
Novartis image

Novartis sales below forecast in ‘transformative’ year

January 28, 2015
Sales and Marketing Diovan, Exforge, Gleevec, Jimenez, Novartis, amlodipine, q4, valsartan

Novartis’ fourth quarter sales have faded slightly as growth in pharmaceuticals is beaten back by generic competition, and the firm …

News
GSK image

GSK denies China job cutting rumours

January 27, 2015
Medical Communications, Research and Development, Sales and Marketing China, GSK, Jobs, Novartis, caixin, pharma

GlaxoSmithKline has told Pharmafile that the news and rumours circulating about 1,000 employees facing the axe in China are not …

News
Novartis image

Novartis earns EMA and FDA nods for Jakavi and Bexsero

January 26, 2015
Sales and Marketing Bexsero, Cancer, EU, FDA, Jakavi, Novartis, US, meningitis, ruxolitinib

Novartis has secured the regulatory go-ahead for two of its drugs, after the EMA recommended Jakavi for a rare blood …

News
Novartis image

Novartis gets FDA approval for psoriasis drug

January 22, 2015
Sales and Marketing Cosentyx, European Commission, FDA, Novartis, Secukinumab, psoriasis

The US Food and Drug Administration (FDA) has shown Novartis’ skin condition drug Cosentyx the green light to treat patients …

News
Novartis image

Novartis enters digital tech collaboration

January 12, 2015
Sales and Marketing Novartis, clinical trials, digital, mhealth, qualcomm, ventures

Novartis has entered an agreement with the US investment company Qualcomm Ventures to create a joint firm to support the …

News
Novartis image

Novartis seeks FDA approval for lung drugs

January 8, 2015
Sales and Marketing Advair, FDA, GSK, NVA237, Novartis, QVA149, Seretide, asthma, lung copd

Novartis has submitted two new lung treatments for FDA approval after ‘robust’ Phase III trial results. If approved, QVA149 and …

News
Sandoz image

Sandoz earns historic first FDA biosimilar vote

January 8, 2015
Sales and Marketing FDA, Humira, Novartis, Sandoz, Zarxio, filgrastim, zarzio

Sandoz has taken a huge step forward in the race to be the first company to market a biosimilar in …

News
Afinitor image

Exclusive: Novartis drug struck off cancer drugs fund

January 8, 2015
Sales and Marketing Afinitor, Jevtana, NHS, NHS England, NICE, Novartis, Sanofi, everolimus

Novartis’ Afinitor (everolimus) will be removed from the Cancer Drugs Fund list when NHS England announces which drugs it can …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025